Home Watchlists Portfolios Indices Forex Futures Crypto Comparisons Alerts Screeners Scans Settings

Amneal Pharmaceuticals (NYSE:AMRX) PT Lowered to $4.00



  • Source: Casper Courier - - Read: 0

    Summary:

     

    Amneal Pharmaceuticals (NYSE:AMRX) had its price objective cut by Raymond James from $5.00 to $4.00 in a research note published on Thursday morning, Stock Target Advisor reports. They currently have an outperform rating on the stock.

    A number of other equities analysts have also weighed in on the stock. Svb Leerink lowered shares of Amneal Pharmaceuticals from an outperform rating to a market perform rating in a research report on Thursday. Leerink Swann lowered shares of Amneal Pharmaceuticals from an outperform rating to a market perform rating in a research report on Thursday. Royal Bank of Canada lowered shares of Amneal Pharmaceuticals from an outperform rating to a sector perform rating and dropped their price target for the stock from $11.00 to $6.00 in a research report on Thur ...

     

     

    Read Full News: https://caspercourier.com/amneal-pharmaceuticals-nyseamrx-pt-lowered-to-4-00/


Log in to reply